RxDoctor Payments Data

Darryl Elzinga, MD

Otolaryngology · Grand Rapids, MINPI 1275524951

Payments from drug & device makers

$678in general payments, 2019–2025

Across 27 payments — averaging $25.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$170
  • Optinose US, Inc.$148
  • GSK$62
  • Xoran Technologies LLC$60
  • Olympus America Inc.$49
  • Medtronic$47
  • plus $141 from 6 others

What the payments were for

  • Food & beverage$678100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron Healthcare Solutions, Inc.3$170
Optinose US, Inc.4$148
GSK3$62
Xoran Technologies LLC3$60
Olympus America Inc.3$49
Medtronic3$47
Stryker2$42
Novartis2$25
Sanofi1$24
Ascendis Pharma Endocrinology Inc1$20
Vertex1$18
Fortovia Therapeutics, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$678 in reported general payments places this provider in the 30th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$51,659
Medicare patients
208
Services billed
470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth26$2,909
Ipratropium Bromide83$2,256
Fluocinolone Acetonide Oil58$1,779
Fluticasone Propionate124$1,684
Omeprazole75$1,078
Azelastine Hcl17$497
Ofloxacin26$431
Montelukast Sodium38$379
Mupirocin45$362
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$284
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid17$273
Methylprednisolone43$250
CefuroximeCefuroxime Axetil18$234
Prednisone49$208
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$115

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →